SG11201506876XA - Modification of polypeptides - Google Patents
Modification of polypeptidesInfo
- Publication number
- SG11201506876XA SG11201506876XA SG11201506876XA SG11201506876XA SG11201506876XA SG 11201506876X A SG11201506876X A SG 11201506876XA SG 11201506876X A SG11201506876X A SG 11201506876XA SG 11201506876X A SG11201506876X A SG 11201506876XA SG 11201506876X A SG11201506876X A SG 11201506876XA
- Authority
- SG
- Singapore
- Prior art keywords
- polypeptides
- modification
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
- C40B50/14—Solid phase synthesis, i.e. wherein one or more library building blocks are bound to a solid support during library creation; Particular methods of cleavage from the solid support
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Computational Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/832,526 US20140274759A1 (en) | 2013-03-15 | 2013-03-15 | Modification of polypeptides |
PCT/EP2014/055204 WO2014140342A1 (en) | 2013-03-15 | 2014-03-14 | Modification of polypeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201506876XA true SG11201506876XA (en) | 2015-09-29 |
Family
ID=50288071
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201506876XA SG11201506876XA (en) | 2013-03-15 | 2014-03-14 | Modification of polypeptides |
Country Status (12)
Country | Link |
---|---|
US (2) | US20140274759A1 (pt) |
EP (1) | EP2970954B1 (pt) |
JP (1) | JP6437468B2 (pt) |
CN (1) | CN105189747B (pt) |
AU (1) | AU2014229994B2 (pt) |
CA (1) | CA2901535C (pt) |
DK (1) | DK2970954T3 (pt) |
ES (1) | ES2700999T3 (pt) |
PL (1) | PL2970954T3 (pt) |
PT (1) | PT2970954T (pt) |
SG (1) | SG11201506876XA (pt) |
WO (1) | WO2014140342A1 (pt) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG11201400888TA (en) | 2011-10-07 | 2014-04-28 | Bicycle Therapeutics Ltd | Modulation of structured polypeptide specificity |
GB201306623D0 (en) | 2013-04-11 | 2013-05-29 | Bicycle Therapeutics Ltd | Modulation of structured polypeptide specificity |
JP2017502921A (ja) * | 2013-10-28 | 2017-01-26 | バイサイクル・セラピューティクス・リミテッド | 新規なポリペプチド |
JP6882978B2 (ja) | 2014-10-29 | 2021-06-02 | バイスクルアールディー・リミテッド | Mt1−mmpに特異的な二環性ペプチドリガンド |
GB201607827D0 (en) | 2016-05-04 | 2016-06-15 | Bicycle Therapeutics Ltd | Bicyclic peptide-toxin conjugates specific for MT1-MMP |
WO2018115203A1 (en) | 2016-12-23 | 2018-06-28 | Bicyclerd Limited | Peptide derivatives having novel linkage structures |
GB201706477D0 (en) | 2017-04-24 | 2017-06-07 | Bicycle Therapeutics Ltd | Modification of polypeptides |
WO2019002842A1 (en) | 2017-06-26 | 2019-01-03 | Bicyclerd Limited | BICYCLIC PEPTIDE LIGANDS WITH DETECTABLE FRACTIONS AND USES THEREOF |
ES2926195T3 (es) * | 2017-08-04 | 2022-10-24 | Bicycletx Ltd | Ligandos peptídicos bicíclicos específicos de CD137 |
WO2019084060A1 (en) | 2017-10-24 | 2019-05-02 | Silverback Therapeutics, Inc. | CONJUGATES AND METHODS OF USE FOR THE SELECTIVE DELIVERY OF IMMUNOMODULATORY AGENTS |
TWI825046B (zh) * | 2017-12-19 | 2023-12-11 | 英商拜西可泰克斯有限公司 | Epha2特用之雙環胜肽配位基 |
GB201721265D0 (en) | 2017-12-19 | 2018-01-31 | Bicyclerd Ltd | Bicyclic peptide ligands specific for EphA2 |
JP2021520378A (ja) * | 2018-04-04 | 2021-08-19 | バイスクルテクス・リミテッド | ヘテロタンデム二環式ペプチド複合体 |
EP3781682A1 (en) * | 2018-04-19 | 2021-02-24 | Stichting VU | Protein macrocyclization |
GB201810316D0 (en) * | 2018-06-22 | 2018-08-08 | Bicyclerd Ltd | Peptide ligands for binding to EphA2 |
US11180531B2 (en) * | 2018-06-22 | 2021-11-23 | Bicycletx Limited | Bicyclic peptide ligands specific for Nectin-4 |
GB201810320D0 (en) * | 2018-06-22 | 2018-08-08 | Bicycletx Ltd | Peptide ligands for binding to CD38 |
GB201810329D0 (en) * | 2018-06-22 | 2018-08-08 | Bicycletx Ltd | Peptide ligands for binding to integrin avB3 |
CN113166113A (zh) | 2018-09-12 | 2021-07-23 | 希沃尔拜克治疗公司 | 取代的苯并氮杂䓬化合物、缀合物及其用途 |
CN113164618A (zh) | 2018-09-12 | 2021-07-23 | 希沃尔拜克治疗公司 | 用免疫刺激性缀合物治疗疾病的方法和组合物 |
US20220306689A9 (en) * | 2018-12-21 | 2022-09-29 | Bicycletx Limited | Bicyclic peptide ligands specific for pd-l1 |
GB201900529D0 (en) * | 2019-01-15 | 2019-03-06 | Bicycletx Ltd | Bicyclic peptide ligands specific for CD38 |
TW202118770A (zh) | 2019-07-30 | 2021-05-16 | 英商拜西可泰克斯有限公司 | 異質雙環肽複合物 |
AU2020331036A1 (en) | 2019-08-15 | 2022-03-03 | Silverback Therapeutics, Inc. | Formulations of benzazepine conjugates and uses thereof |
GB201914233D0 (en) | 2019-10-02 | 2019-11-13 | Bicyclerd Ltd | Phage cyclisation assay |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0913775D0 (en) | 2009-08-06 | 2009-09-16 | Medical Res Council | Multispecific peptides |
-
2013
- 2013-03-15 US US13/832,526 patent/US20140274759A1/en not_active Abandoned
-
2014
- 2014-03-14 PL PL14710558T patent/PL2970954T3/pl unknown
- 2014-03-14 CA CA2901535A patent/CA2901535C/en active Active
- 2014-03-14 ES ES14710558T patent/ES2700999T3/es active Active
- 2014-03-14 PT PT14710558T patent/PT2970954T/pt unknown
- 2014-03-14 EP EP14710558.9A patent/EP2970954B1/en active Active
- 2014-03-14 CN CN201480014384.0A patent/CN105189747B/zh active Active
- 2014-03-14 SG SG11201506876XA patent/SG11201506876XA/en unknown
- 2014-03-14 AU AU2014229994A patent/AU2014229994B2/en active Active
- 2014-03-14 JP JP2015562247A patent/JP6437468B2/ja active Active
- 2014-03-14 WO PCT/EP2014/055204 patent/WO2014140342A1/en active Application Filing
- 2014-03-14 DK DK14710558.9T patent/DK2970954T3/da active
-
2015
- 2015-09-10 US US14/849,637 patent/US9932367B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CA2901535A1 (en) | 2014-09-18 |
AU2014229994B2 (en) | 2020-03-05 |
JP6437468B2 (ja) | 2018-12-12 |
PT2970954T (pt) | 2018-12-17 |
DK2970954T3 (da) | 2019-01-02 |
CN105189747A (zh) | 2015-12-23 |
EP2970954B1 (en) | 2018-10-24 |
ES2700999T3 (es) | 2019-02-20 |
US20160031939A1 (en) | 2016-02-04 |
WO2014140342A1 (en) | 2014-09-18 |
EP2970954A1 (en) | 2016-01-20 |
US9932367B2 (en) | 2018-04-03 |
JP2016527180A (ja) | 2016-09-08 |
CA2901535C (en) | 2021-06-22 |
US20140274759A1 (en) | 2014-09-18 |
CN105189747B (zh) | 2019-03-08 |
AU2014229994A1 (en) | 2015-09-17 |
PL2970954T3 (pl) | 2019-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201506876XA (en) | Modification of polypeptides | |
HK1216756A1 (zh) | 新的多肽 | |
HK1217499A1 (zh) | 蛋白的多聚形式 | |
GB201311475D0 (en) | Polypeptides | |
SG11201602889TA (en) | Novel polypeptides | |
EP2997036A4 (en) | CLEANING OF RECOMBINANT MANUFACTURED POLYPEPTIDES | |
HRP20180452T1 (hr) | Peptidi | |
PL3061771T3 (pl) | Nowy peptyd o czterech połączonych epitopach dla ctl | |
GB201308057D0 (en) | Protein | |
GB201309421D0 (en) | Polypeptides | |
HK1198769A1 (en) | Novel peptide | |
GB201315130D0 (en) | Peptides | |
GB201401955D0 (en) | Protein | |
ZA201506407B (en) | New polypeptides | |
PL3080276T3 (pl) | Polipeptydy toksyczne dla owadów | |
GB201318941D0 (en) | Novel polypeptides | |
HK1198422A1 (en) | Novel uses of colossolactones | |
AU4959P (en) | DP401 Dianella prunina x caerulea | |
PL3071575T3 (pl) | Wytwarzanie normorfinanów | |
GB201304608D0 (en) | BenTime of Yisrael operable arrangement | |
TWM475821U (en) | Structure of mosquito-catch | |
TWM475524U (en) | Structure of rivet-pulling | |
AU2013105V (en) | DCGL Dianella caerulea | |
HUP1300040A2 (en) | Gluten-free flourmix | |
GB201322342D0 (en) | Procedure |